Cited by 1,131Bone Tissue Engineering MaterialsTGF-β signaling in diseasesBone Metabolism and Diseases

A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2

Open access
James, Aaron W., LaChaud, Gregory, Shen, Jia, Asatrian, Greg, Nguyen, Vi, Zhang, Xinli, Ting, Kang, Soo, Chia·2016·Tissue Engineering Part B: Reviews

Abstract

Bone morphogenetic protein-2 (BMP-2) is currently the only Food and Drug Administration (FDA)-approved osteoinductive growth factor used as a bone graft substitute. However, with increasing clinical use of BMP-2, a growing and well-documented side effect profile has emerged. This includes postoperative inflammation and associated adverse effects, ectopic bone formation, osteoclast-mediated bone resorption, and inappropriate adipogenesis. Several large-scale studies have confirmed the relative frequency of adverse events associated with the clinical use of BMP-2, including life-threatening cervical spine swelling. In fact, the FDA has issued a warning of the potential life-threatening complications of BMP-2. This review summarizes the known adverse effects of BMP-2, including controversial areas such as tumorigenesis. Next, select animal models that replicate BMP-2's adverse clinical effects are discussed. Finally, potential molecules to mitigate the adverse effects of BMP-2 are reviewed. In summary, BMP-2 is a potent osteoinductive cytokine that has indeed revolutionized the bone graft substitute market; however, it simultaneously has accrued a worrisome side effect profile. Better understanding of these adverse effects among both translational scientists and clinicians will help determine the most appropriate and safe use of BMP-2 in the clinical setting.

Integrity signals

Registry

Crossref · 10.1089/ten.teb.2015.0357

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • More widespread use of rhBMP-2 delivery from collagen sponges in long bone nonunions has been limited, in part due to safety concerns including edema, inflammation, ectopic bone formation, and bone cysts.

    “While off-label use is permitted, more widespread use of these products in long bone nonunions has been limited, in part due to safety concerns including edema, inflammation, ectopic bone formation, and bone cysts [8].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C.
Affiliations
University of California, Los Angeles (US)
Corresponding author
  • Ting, Kang
  • Soo, Chia
Venue
Tissue Engineering Part B: Reviews
Published
2016-08
Volume
22
Issue
4
Pages
284-297
ISSN
  • 1937-3368 (ISSN-L)
  • 1937-3376
OpenAlex
W2261324366
Cited by
1,131
References
183
Citations by year
2026: 127 · 2025: 124 · 2024: 130 · 2023: 161 · 2022: 124 · 2021: 143 · 2020: 119 · 2019: 82 · 2018: 72 · 2017: 37 · 2016: 10 · 2013: 1
FWCI
4.79
Type
journal article
Language
en
Open access
Locations
  • Tissue Engineering Part B Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Musculoskeletal Transplant Foundation (K08 AR068316)
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR061399, K08AR068316, R01AR066782)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
BMP-2, bone graft substitutes, ectopic bone formation, osteoclast resorption, adipogenesis, postoperative inflammation, carcinogenesis, osteoinduction
MeSH terms
Animals, Bone Resorption, Humans, Spinal Fusion, Transforming Growth Factor beta, Bone Morphogenetic Protein 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review